Carlson Capital Management Eli Lilly & CO Transaction History

Carlson Capital Management

$1.26 Billion
Q1 2024

A detailed history of Carlson Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Carlson Capital Management holds 2,386 shares of LLY stock, worth $2.18 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

2,386

Previous 2,620 8.93%

Holding current value

$2.18 Million

Previous $1.53 Million 21.55%

% of portfolio

0.15%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$592.2 - $792.28 $138,574 - $185,393	-234 Reduced 8.93%	2,386 $1.86 Million
Q4 2023 Jan 16, 2024	SELL	$525.19 - $619.13 $17,331 - $20,431	-33 Reduced 1.24%	2,620 $1.53 Million
Q3 2023 Nov 21, 2023	BUY	$434.7 - $599.3 $1,738 - $2,397	4 Added 0.15%	2,653 $1.43 Million
Q2 2023 Jul 24, 2023	SELL	$350.74 - $468.98 $347,934 - $465,228	-992 Reduced 27.25%	2,649 $1.24 Million
Q1 2023 Apr 17, 2023	BUY	$310.63 - $364.82 $2,174 - $2,553	7 Added 0.19%	3,641 $1.25 Million

Q4 2022 Feb 03, 2023	SELL	$321.55 - $374.67 $643 - $749	-2 Reduced 0.06%	3,634 $1.33 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $29,351 - $33,449	99 Added 2.8%	3,636 $1.18 Million
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $140,479 - $164,944	-504 Reduced 12.47%	3,537 $1.15 Million
Q1 2022 May 24, 2022	BUY	$234.69 - $291.66 $4,693 - $5,833	20 Added 0.5%	4,041 $1.16 Million
Q4 2021 Jan 14, 2022	BUY	$224.85 - $279.04 $7,644 - $9,487	34 Added 0.85%	4,021 $1.11 Million
Q3 2021 Oct 12, 2021	BUY	$221.6 - $272.71 $1,551 - $1,908	7 Added 0.18%	3,987 $921,000
Q2 2021 Jul 12, 2021	BUY	$180.55 - $233.54 $5,055 - $6,539	28 Added 0.71%	3,980 $913,000
Q1 2021 Apr 12, 2021	BUY	$164.32 - $212.72 $13,638 - $17,655	83 Added 2.15%	3,952 $738,000
Q4 2020 Jan 11, 2021	BUY	$130.46 - $172.63 $3,000 - $3,970	23 Added 0.6%	3,869 $644,000
Q3 2020 Oct 13, 2020	BUY	$146.22 - $169.13 $1,315 - $1,522	9 Added 0.23%	3,846 $569,000
Q2 2020 Jul 13, 2020	BUY	$136.42 - $164.18 $14,869 - $17,895	109 Added 2.92%	3,837 $627,000
Q1 2020 Apr 27, 2020	SELL	$119.05 - $147.35 $14,881 - $18,418	-125 Reduced 3.24%	3,728 $607,000
Q4 2019 Jan 27, 2020	BUY	$106.92 - $132.43 $2,779 - $3,443	26 Added 0.68%	3,853 $506,000
Q3 2019 Oct 29, 2019	BUY	$106.79 - $116.16 $3,524 - $3,833	33 Added 0.87%	3,827 $428,000
Q2 2019 Jul 15, 2019	SELL	$110.79 - $129.32 $5,317 - $6,207	-48 Reduced 1.25%	3,794 $420,000
Q1 2019 Apr 25, 2019	SELL	$111.31 - $131.02 $174,200 - $205,046	-1,565 Reduced 28.94%	3,842 $499,000
Q4 2018 Jan 22, 2019	SELL	$105.9 - $118.64 $125,067 - $140,113	-1,181 Reduced 17.93%	5,407 $626,000
Q3 2018 Oct 19, 2018	SELL	$85.86 - $107.31 $6,782 - $8,477	-79 Reduced 1.18%	6,588 $707,000
Q2 2018 Jul 26, 2018	BUY	$75.7 - $86.88 $1,968 - $2,258	26 Added 0.39%	6,667 $569,000
Q1 2018 Apr 20, 2018	SELL	$74.21 - $87.6 $11,873 - $14,016	-160 Reduced 2.35%	6,641 $514,000
Q4 2017 Jan 08, 2018	BUY	$81.94 - $87.89 $7,538 - $8,085	92 Added 1.37%	6,801 $574,000
Q3 2017 Oct 16, 2017	BUY	$77.07 - $85.54 $517,062 - $573,887	6,709	6,709 $574,000

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlson Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Carlson Capital Management with notifications on news.

Account

Carlson Capital Management Eli Lilly & CO Transaction History